Emyria Share Price and Company Fundamentals
Last traded: Today at 4:53 AM
Emyria Limited engages in delivering and developing of treatments for mental health and select neurological conditions in Australia. The company operates through Clinical Services, Clinical Services, and corporate segments. It provides therapy programs for post-traumatic stress disorder (PTSD) and treatment-resistant depression. The company also develops ultra-pure CBD capsules (EMD-RX7, and EMD-RX9) and proprietary MDMA analogues, as well as provides psychological trauma care facility under the Pax Centre name. It has a collaboration partnership with the University of Western Australia to support the expand Emyria's MDMA analogue drug development program. The company was formerly known as Emerald Clinics Limited and changed its name to Emyria Limited in September 2020. Emyria Limited was incorporated in 2018 and is headquartered in Leederville, Australia.
Key Metrics
PE ratio
-
PB ratio
6.44
Dividend yield
-
Beta
0.06
Market cap
$46.78M
Enterprise value
$33.12M
Company profile
| Industry / Sector | Health Information Services / Healthcare |
|---|---|
| Website | https://emyria.com |
| Mailing address | D2, 661 Newcastle Street Leederville WA 6007 Australia |
| Phone / Fax | 61 8 6559 2800 / 61 8 6559 2800 |
Dividends
More: Emyria Dividend history, yield and payout ratio
Dividend yield
-
Dividend amount
$-
Payout ratio
0.00%
5Y Avg. yield
-%
Emyria paid $- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.EMD dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Emyria.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Gregory Hutchinson | Executive Chairman | ||
| Dr. Michael Winlo | Chief Scientific Officer & Executive Director | ||
| Mr. Joseph Daniel Ohayon ACA, MBA Intl Bus. | Chief Financial Officer | ||
| Dr. Alistair Vickery | Executive Medical Director & Director | ||
| Ms. Tracie Ernenwein | Head of Research & Drug Development | ||
| Mary-Ann Rennie | Head of Corporate Operations | ||
| Ms. Susan Patricia Park A.C.A., A.C.I.S., ACSA, AGIA, B.Com., C.A., F Fin | Company Secretary | 50 |
Profitability and management effectiveness
Profit margin
-225.33%
Operating margin
-260.90%
Return on assets
-25.88%
Return on equity
-81.31%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Emyria is 46.78M and its enterprise value is 33.12M. The enterprise value to revenue ratio of EMD is 23.75. The enterprise value to EBITDA ratio of EMD is -13.84.
The EMD's stocks Beta value is 0.06 making it 94% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Emyria (EMD)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Pro Medicus (PME)
- Polynovo (PNV)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Emyria (ASX:EMD) Frequently Asked Questions
1. What is Emyria's Stock Symbol?
Emyria trades on ASX under the ticker symbol "EMD".
2. What is Emyria's stock price today?
One share of EMD stock can currently be purchased for approximately $0.058.
3. How can I contact Emyria?
Emyria's mailing address is D2, 661 Newcastle Street Leederville WA 6007 Australia. The company can be reached via phone at 61 8 6559 2800.
4. What is Emyria's official website?
The official website of Emyria is https://emyria.com.